Homologous to human SMYD1, but contains an unexpected C-terminal tail-anchor segment. Localization: Inner nuclear membrane (by feature)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0016020 | membrane | 2 | 10 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: E9ACZ3
Term | Name | Level | Count |
---|---|---|---|
GO:0006479 | protein methylation | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008213 | protein alkylation | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016570 | histone modification | 5 | 2 |
GO:0016571 | histone methylation | 5 | 2 |
GO:0018022 | peptidyl-lysine methylation | 5 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018205 | peptidyl-lysine modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034968 | histone lysine methylation | 6 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0008168 | methyltransferase activity | 4 | 2 |
GO:0008170 | N-methyltransferase activity | 5 | 2 |
GO:0008276 | protein methyltransferase activity | 3 | 2 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 2 |
GO:0016278 | lysine N-methyltransferase activity | 6 | 2 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 2 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 5 | 2 |
GO:0042054 | histone methyltransferase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.233 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.552 |
CLV_PCSK_FUR_1 | 140 | 144 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.243 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 247 | 249 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 212 | 214 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.242 |
CLV_PCSK_SKI1_1 | 205 | 209 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.233 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.663 |
DOC_CKS1_1 | 60 | 65 | PF01111 | 0.500 |
DOC_CYCLIN_RxL_1 | 69 | 78 | PF00134 | 0.536 |
DOC_CYCLIN_yCln2_LP_2 | 238 | 244 | PF00134 | 0.412 |
DOC_MAPK_gen_1 | 140 | 147 | PF00069 | 0.475 |
DOC_MAPK_gen_1 | 183 | 193 | PF00069 | 0.410 |
DOC_MAPK_gen_1 | 224 | 233 | PF00069 | 0.475 |
DOC_MAPK_MEF2A_6 | 125 | 132 | PF00069 | 0.433 |
DOC_MAPK_MEF2A_6 | 226 | 235 | PF00069 | 0.362 |
DOC_MAPK_RevD_3 | 234 | 248 | PF00069 | 0.336 |
DOC_PP2B_LxvP_1 | 238 | 241 | PF13499 | 0.412 |
DOC_SPAK_OSR1_1 | 134 | 138 | PF12202 | 0.536 |
DOC_SPAK_OSR1_1 | 248 | 252 | PF12202 | 0.399 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 167 | 171 | PF00917 | 0.536 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.443 |
LIG_14-3-3_CanoR_1 | 72 | 77 | PF00244 | 0.462 |
LIG_APCC_ABBA_1 | 145 | 150 | PF00400 | 0.433 |
LIG_BRCT_BRCA1_1 | 114 | 118 | PF00533 | 0.443 |
LIG_BRCT_BRCA1_1 | 77 | 81 | PF00533 | 0.443 |
LIG_EH1_1 | 70 | 78 | PF00400 | 0.457 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.501 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.433 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.500 |
LIG_LIR_Gen_1 | 131 | 139 | PF02991 | 0.536 |
LIG_LIR_Gen_1 | 165 | 176 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 232 | 243 | PF02991 | 0.283 |
LIG_LIR_Gen_1 | 53 | 63 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 78 | 87 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 131 | 135 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 189 | 195 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 232 | 238 | PF02991 | 0.283 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.433 |
LIG_LRP6_Inhibitor_1 | 166 | 172 | PF00058 | 0.336 |
LIG_Pex14_2 | 5 | 9 | PF04695 | 0.646 |
LIG_PTB_Apo_2 | 170 | 177 | PF02174 | 0.536 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.443 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.536 |
LIG_SH2_GRB2like | 153 | 156 | PF00017 | 0.433 |
LIG_SH2_SRC | 153 | 156 | PF00017 | 0.536 |
LIG_SH2_STAT3 | 121 | 124 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 245 | 248 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.411 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.433 |
LIG_SUMO_SIM_anti_2 | 45 | 51 | PF11976 | 0.433 |
LIG_SUMO_SIM_par_1 | 126 | 131 | PF11976 | 0.433 |
LIG_SUMO_SIM_par_1 | 72 | 78 | PF11976 | 0.536 |
LIG_TRAF2_1 | 62 | 65 | PF00917 | 0.429 |
LIG_TYR_ITIM | 166 | 171 | PF00017 | 0.443 |
MOD_CK1_1 | 75 | 81 | PF00069 | 0.453 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.413 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.484 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.233 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.243 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.233 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.260 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.759 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.438 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.447 |
MOD_N-GLC_1 | 1 | 6 | PF02516 | 0.454 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.313 |
MOD_N-GLC_1 | 154 | 159 | PF02516 | 0.336 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.654 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.450 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.479 |
MOD_NEK2_2 | 167 | 172 | PF00069 | 0.366 |
MOD_Plk_1 | 1 | 7 | PF00069 | 0.742 |
MOD_Plk_1 | 116 | 122 | PF00069 | 0.457 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.480 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.389 |
MOD_Plk_1 | 216 | 222 | PF00069 | 0.484 |
MOD_Plk_2-3 | 117 | 123 | PF00069 | 0.443 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.536 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.283 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.472 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.443 |
TRG_DiLeu_BaLyEn_6 | 124 | 129 | PF01217 | 0.433 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.443 |
TRG_ER_diArg_1 | 139 | 142 | PF00400 | 0.475 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.351 |
TRG_Pf-PMV_PEXEL_1 | 183 | 187 | PF00026 | 0.336 |
TRG_Pf-PMV_PEXEL_1 | 248 | 252 | PF00026 | 0.599 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HWF5 | Leptomonas seymouri | 90% | 79% |
A0A0S4IND3 | Bodo saltans | 57% | 78% |
A0A1X0NLS4 | Trypanosomatidae | 71% | 78% |
A0A3Q8IG56 | Leishmania donovani | 97% | 100% |
A0A422NXJ8 | Trypanosoma rangeli | 72% | 78% |
A4HFD4 | Leishmania braziliensis | 94% | 100% |
A4I360 | Leishmania infantum | 97% | 100% |
C9ZKV5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 78% |
E9AYR8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5BGA9 | Trypanosoma cruzi | 72% | 72% |